Coagulation Factor X Promotes Resistance to Androgen-Deprivation Therapy in Prostate Cancer

Medicine, Urology, Oncology, Life Sciences, Biochemistry, Immunology,
prostate cancer   androgen-deprivation therapy   coagulation factor X   immunosuppression   tumor microenvironment  

Study on the Role of Coagulation Factor X in Anti-androgen Resistance in Prostate Cancer Research Background Prostate cancer (PCa) is the second most common cancer in men worldwide and is one of the leading causes of cancer-related deaths. The occurrence and progression of prostate cancer are highly dependent on the androgen receptor (AR) signaling...

Targeting HSP90AB1 and PARP1 to Enhance Anticancer Therapy in Prostate Cancer

Medicine, Oncology, Life Sciences, Cell Biology, Biochemistry,
prostate cancer   HSP90AB1   PARP1   olaparib   cell survival   PI3K/AKT pathway   combination therapy  

Therapeutic Potential of Synergistic Targeted Inhibition of HSP90AB1 and PARP1 in Prostate Cancer Cells: A Review of Celastrol and Olaparib Combination Therapy Background Prostate Cancer (PCA) is one of the most common malignancies among men worldwide, with its incidence continually rising in recent years, making early screening and treatment cruci...

Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients with Advanced Prostate Cancer from Latin America: Challenges and Future Approaches

Medicine, Basic Medical Sciences, Geriatrics, Urology, Oncology, Life Sciences, Genetics,
homologous recombination repair   gene mutation   prostate cancer   Latin America   prospective study  

Academic Report for the Paper Titled “Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients with Advanced Prostate Cancer from Latin America: Challenges and Future Approaches” Background Prostate cancer is one of the most common cancers among men in Latin America and the Caribbean (LAC). According to the 2020 Glo...